Clinical Trial Update: A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating scheduled gradual reduction with varenicline for smoking cessation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Nicotine Addiction | Phase 4 | Status: TERMINATED